Mallinckrodt accused of blocking competition for pain pills in US
MLex Summary: Mallinckrodt has been accused in a US complaint of illegally monopolizing the market for the manufacture and sale of pain pills containing Oxycodone and the Acetaminophen USP by refusing...To view the full article, register now.
Already a subscriber? Click here to view full article